CRIS - Curis - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRIS is currently covered by 5 analysts with an average price target of $3.91. This is a potential upside of $1.45 (58.94%) from yesterday's end of day stock price of $2.46.

Curis's activity chart (see below) currently has 17 price targets and 36 ratings on display. The stock rating distribution of CRIS is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 73.99% with an average time for these price targets to be met of 239.11 days.

Highest price target for CRIS is $17, Lowest price target is $16, average price target is $29.75.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 19-May-2025. First documented stock forecast 08-May-2014.

Currently out of the existing stock ratings of CRIS, 16 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$17

$15 (750.00%)

11 days ago
(19-May-2025)

5/7 (71.43%)

$14.92 (717.31%)

1264

Buy

$16

$14 (700.00%)

1 months 29 days ago
(31-Mar-2025)

4/9 (44.44%)

$13.9 (661.90%)

41

Buy

$26

$24 (1200.00%)

$26

1 years 15 days ago
(15-May-2024)

0/2 (0%)

$13 (100.00%)

Buy

$12

1 years 15 days ago
(15-May-2024)

1/1 (100%)

$-18 (-60.00%)

252

Buy

$60

$58 (2900.00%)

$480

1 years 10 months 19 days ago
(11-Jul-2023)

2/4 (50%)

$43.19 (256.93%)

146

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CRIS (Curis) average time for price targets to be met?

On average it took 239.11 days on average for the stock forecasts to be realized with a an average price target met ratio 73.99

Which analyst has the current highest performing score on CRIS (Curis) with a proven track record?

ALETHIA YOUNG

Which analyst has the current lower performing score on CRIS (Curis) with a proven track record?

ROBYN KARNAUSKAS

Which analyst has the most public recommendations on CRIS (Curis)?

Alethia Young works at CANTOR FITZGERALD and has 5 price targets and 5 ratings on CRIS

Which analyst is the currently most bullish on CRIS (Curis)?

Alethia Young with highest potential upside - $58

Which analyst is the currently most reserved on CRIS (Curis)?

John Walsh with lowest potential downside - -$0.07

Curis in the News

Earnings Preview: Insmed (INSM) Q1 Earnings Expected to Decline

The market expects Insmed (INSM) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is important in assessing the company’s earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?